APG APi Group Corp Insider Trading

Director Martin E Franklin sold 2,000,000 shares of APG at $42.08 for $84,160,000.00; post-trade holdings: 19,240,426 shares.

Martin E Franklin sold 2,000,000 shares (2.00M shares) at $42.08 on 2026-06-11 for $84,160,000.00 ($84.2M), reducing his stake by 9.4% to 19,240,426 shares. At his same ticker (APG), all 4 prior measurable sells resulted in subsequent stock gains: 30-day returns of +14.4%, +7.2%, +8.6%, +10.0%, and +5.3%, with 90-day returns of +16.2%, +17.7%, +19.1%, and +13.0%. His cross-ticker track record shows a 62.50% well-timed sell rate across 17 prior sales, but the 0 of 4 well-timed 90-day outcomes at APG specifically stand in contrast. The current stock price of $42.33 is -15.3% from the 52-week high of $49.99, suggesting the sale occurred in a context of recent price softness.

Director Ian G H Ashken sells 1,084,000 shares (1.08M) for $48.5M via 10b5-1 plan; holds 9.48M post-transaction

Ian G H Ashken executed five separate sales totaling 1,084,000 shares for $48,536,903.76 (blended average $44.78) on 2026-05-04 and 2026-05-05, reducing his holdings from 10,561,284 to 9,477,284 shares (a -10.3% reduction). This sale is part of a pre-arranged 10b5-1 trading plan adopted 2025-05-07 and is therefore scheduled rather than discretionary. The stock currently trades at $41.14, down 12.0% over the past 30 days and down 6.8% over 90 days, placing it 17.7% below its 52-week high of $49.99. Across his cross-ticker track record, Ashken's 20 prior sells show an average 30-day return of -20.0% and 90-day return of -15.4%, though his five prior sales at APG specifically show mixed results (ranging from -6.7% to -0.2% at 90 days). The company's fundamentals show quarterly revenue of $1,982,000,000.00 and annual growth of +12.7%, but the elevated P/E of 54.85 and recent downward price momentum warrant investor attention to the broader valuation and market context.

Director Lillie sells 360,000 shares (22.0% of holdings) for $16,201,173.81 via scheduled 10b5-1 plan at APG

James E Lillie executed 8 separate sales totaling 360,000 shares for $16,201,173.81 on 2026-05-04 and 2026-05-05 at a blended average price of $45.00, reducing his holdings from 1,635,019 shares to 1,275,019 shares. This transaction was executed under a pre-arranged 10b5-1 trading plan adopted on 2025-05-09, meaning it was scheduled rather than discretionary. The current stock price of $41.14 is -17.7% from the 52-week high of $49.99 and has declined -12.0% over the past 30 days and -6.8% over 90 days. Lillie's cross-ticker track record shows 20 prior sells with average 30-day returns of -8.4% and average 90-day returns of -4.4%; his prior same-ticker sales at APG on 2026-03-04 and 2026-03-03 were followed by 90-day returns ranging from -3.5% to -1.6%.

Director Franklin Martin E sold 3,000,000 shares of APG at $40.88 for $122.6M on 2026-03-19

Director Franklin Martin E executed a $122,640,000.00 sale of 3,000,000 APG shares at $40.88, reducing his holdings by 12.4% to 21,240,426 shares post-transaction. His prior sales at APG show a consistent pattern of poor timing: all 5 recent trades at this ticker generated positive 90-day returns averaging +16.2%, indicating he sold before subsequent rallies rather than before declines. At the cross-ticker level, his 16 prior sells averaged -17.1% 30-day return and -13.7% 90-day return with a 62.50% well-timed rate, yet his APG-specific record contradicts this strength—0 of 5 prior sells at this ticker were well-timed. APG's current fundamentals show revenue of $2,085,000,000.00 and annual growth of +12.7%, but valuation is elevated at P/E 54.92. The stock is down 9.0% from its 52-week high of $45.29, trading at $41.19 after a -7.3% 30-day decline.

Director Ian G H Ashken sells 300,000 shares at $43.52 blended price for $13.1M via scheduled 10b5-1 plan

Director Ian G H Ashken executed 5 separate sales totaling 300,000 shares for $13,055,265.96 across three trading days (March 2-4, 2026), with prices ranging from $42.94 to $44.52. This sale reduces his holdings from 10,861,284 shares to 10,561,284 shares, a -2.8% reduction in his position at APi Group Corp. The transaction was executed under a pre-arranged 10b5-1 trading plan adopted on 2025-05-07, meaning it was scheduled rather than discretionary. The multi-day execution across a narrow price band suggests a methodical liquidation of a smaller portion of a substantial remaining stake.

Director Lillie James E sold 360,000 shares of APG at blended $43.49 for $15.7M under 10b5-1 plan, reducing stake to 9.52M shares

Director Lillie James E executed 12 separate sales totaling 360,000 shares for $15,655,216.34 over March 2–4, 2026, at prices ranging from $42.94 to $44.51. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-05-09, meaning the sales were scheduled and non-discretionary. The 360,000-share reduction represents a -3.6% decrease in her pre-transaction holdings, bringing her post-transaction position to 9,522,350 shares. As a scheduled program, this filing discloses systematic execution rather than a discretionary market-timing decision.

CFO Jackola Glenn David sells 18,000 APG shares at $44.23, reducing stake by 52.3% to 16.4K shares

Jackola Glenn David, EVP & Chief Financial Officer of APi Group Corp, sold 18,000 shares on 2026-02-27 at $44.23, reducing his holdings from 34,440 shares to 16.4K shares—a material 52.3% reduction in his position. The stock currently trades at $43.29, just 4.4% below its 52-week high of $45.29, suggesting the sale occurred near recent strength. APG trades at a notable valuation multiple of 57.72 P/E with strong fundamentals including quarterly revenue of $2.1B, net income of $93.0M, and 12.7% annual revenue growth, indicating a profitable high-growth company. A CFO's disposal of more than half his holdings warrants attention to discern whether this reflects personal portfolio rebalancing, broader confidence levels at the executive level, or other factors—particularly given the elevated valuation context.

APi Group Director Malkin buys 7,000 shares across 3 transactions for $275,720.00 in Dec 2025

Director Anthony E Malkin executed 3 separate purchases totaling 7,000 shares for $275,720.00 between November 26 and December 10, 2025, at prices ranging from $39.03 to $39.58 (blended average $39.39), establishing a new position where he held zero shares pre-transaction. The stock is currently trading at $41.87, up 4.9% over 30 days and 23.0% over 90 days, near its 52-week high of $41.87. The sequential buying across multiple dates within a two-week window combined with the modest subsequent price appreciation to $41.87 reflects price action consistent with recent upward momentum in the equity, though the P/E of 64.42 places the company in elevated valuation territory relative to its annual revenue growth of +1.3%.

Director Franklin Martin E sells 900,000 APG shares for $32.3M via scheduled 10b5-1 plan (adopted 2025-05-08), reducing stake to 18.97M shares.

Director Franklin Martin E executed 5 separate sales totaling 900,000 shares for $32,342,702.09 over three trading days (November 3–5, 2025) at a blended average price of $35.94. This transaction was conducted under a pre-arranged 10b5-1 trading plan adopted on 2025-05-08, meaning the sales were scheduled and not subject to discretionary timing decisions. The sales reduced his holdings from 19,868,790 shares to 18,968,790 shares, a -4.5% reduction. Since this is a scheduled disposition under a predetermined plan, no inference about the director's current conviction or near-term outlook can be drawn from the timing or pricing of the individual tranches.

Director Franklin Martin E sold 1,200,000 shares of APG at $34.64 on 2025-09-02 via 10b5-1 plan; retains 19,868,790 shares.

Franklin Martin E, a director at APi Group Corp, sold 1,200,000 shares at $34.64 on 2025-09-02 under a pre-arranged 10b5-1 trading plan adopted on 2025-05-08. This reduces his shareholdings by 5.7% to 19,868,790 shares while generating $41,568,000.00 in proceeds. Because the sale is governed by a scheduled trading plan rather than discretionary timing, no inferences about forward-looking conviction or concerns can be drawn from the trade itself.